GlobeNewswire: Medibio Limited Contains the last 10 of 43 releaseshttp://www.globenewswire.com/External?Length=42024-03-29T13:09:28ZGlobeNewswirehttp://www.globenewswire.com/External?Length=4newsdesk@globenewswire.com (NewsDesk)https://www.globenewswire.com/news-release/2018/11/27/1657522/0/en/Medibio-Signs-Insurance-Company-AIA-Australia-Ltd-AIAA-For-an-Exclusive-Pilot-Program-For-ilumen.html?f=22&fvtc=4&fvtv=34599Medibio Signs Insurance Company AIA Australia Ltd (AIAA) For an Exclusive Pilot Program For ilumen™2018-11-27T14:00:00Z<![CDATA[SYDNEY, Australia and MINNEAPOLIS, Nov. 27, 2018 (GLOBE NEWSWIRE) -- Medibio Limited (MEB or the Company)(ASX: MEB)(OTCQB: MDBIF), a mental health technology company announces that it has signed an exclusive agreement with AIAA to undertake a pilot program for the latest release of its corporate health program, ilumen™.]]>https://www.globenewswire.com/news-release/2018/11/02/1642093/0/en/Medibio-Appoints-Global-Healthcare-Medical-Device-Leader-as-CEO-and-Managing-Director.html?f=22&fvtc=4&fvtv=34599Medibio Appoints Global Healthcare & Medical Device Leader as CEO and Managing Director2018-11-02T13:09:34Z<![CDATA[SYDNEY, Australia and MINNEAPOLIS, Nov. 02, 2018 (GLOBE NEWSWIRE) -- Medibio Limited (MEB or the Company)(ASX: MEB)(OTCQB: MDBIF), a mental health technology company, announces the appointment of David B. Kaysen as CEO and Managing Director.]]>https://www.globenewswire.com/news-release/2018/11/02/1642085/0/en/Medibio-Market-Update.html?f=22&fvtc=4&fvtv=34599Medibio Market Update2018-11-02T13:00:00Z<![CDATA[SYDNEY, Australia and MINNEAPOLIS, Minn., Nov. 02, 2018 (GLOBE NEWSWIRE) -- Medibio Limited (MEB or the Company) (ASX: MEB)(OTCQB: MDBIF), a mental health technology company, today shares a market update to the recent quarterly update.]]>https://www.globenewswire.com/news-release/2018/10/30/1639335/0/en/Medibio-Limited-Quarterly-ASX-Update-and-Cashflows.html?f=22&fvtc=4&fvtv=34599Medibio Limited Quarterly ASX Update and Cashflows2018-10-30T14:52:47Z<![CDATA[Quarterly Update and Message from Medibio Limited]]>https://www.globenewswire.com/news-release/2018/10/24/1626314/0/en/Medibio-Signs-ilumen-Corporate-Contract-with-a-Large-Australian-Employer.html?f=22&fvtc=4&fvtv=34599Medibio Signs ilumen™ Corporate Contract with a Large Australian Employer2018-10-24T13:00:00Z<![CDATA[SYDNEY, Australia and MINNEAPOLIS, Oct. 24, 2018 (GLOBE NEWSWIRE) -- Medibio Limited (MEB or the Company) (ASX: MEB) (OTCQB: MDBIF), a mental health technology company, announces a contract for the latest release of its corporate health program, ilumen™.]]>https://www.globenewswire.com/news-release/2018/10/15/1621326/0/en/Receipt-of-3-146-835-R-D-Tax-Incentive-Refund.html?f=22&fvtc=4&fvtv=34599Receipt of $3,146,835 R&D Tax Incentive Refund2018-10-15T14:00:00Z<![CDATA[SYDNEY, Australia and MINNEAPOLIS, Minn., Oct. 15, 2018 (GLOBE NEWSWIRE) -- Medibio Limited (MEB or the Company)(ASX: MEB)(OTCQB: MDBIF), a mental health technology company, is pleased to announce that it has received $3,146,835 from the Australian Taxation Office under the Research and Development Tax Incentive Program. The cash refund is related to expenditure on eligible Australian and Overseas R&D activities conducted during the financial year ended 30 June 2018.]]>https://www.globenewswire.com/news-release/2018/10/08/1617989/0/en/Medibio-Technology-Honored-with-Two-Presentations-at-Mayo-Clinic-Convergence-Neuroscience-2018.html?f=22&fvtc=4&fvtv=34599Medibio Technology Honored with Two Presentations at Mayo Clinic Convergence Neuroscience 20182018-10-08T13:00:00Z<![CDATA[SYDNEY, Australia and MINNEAPOLIS, Oct. 08, 2018 (GLOBE NEWSWIRE) -- Medibio Limited (MEB or the Company)(ASX: MEB)(OTCQB: MDBIF), a mental health technology company, is happy to announce that two clinical abstracts by Dr. Archie Defillo et al. have been accepted for presentation as part of the Mayo Clinic Convergence Neuroscience 2018 Course. Both presentations are based on the recently completed DX04 clinical study.]]>https://www.globenewswire.com/news-release/2018/10/05/1617426/0/en/Medibio-Provides-Updated-Company-Presentation.html?f=22&fvtc=4&fvtv=34599Medibio Provides Updated Company Presentation2018-10-05T13:00:00Z<![CDATA[SYDNEY, Australia and MINNEAPOLIS, Oct. 05, 2018 (GLOBE NEWSWIRE) -- Medibio Limited (MEB or the Company)(ASX: MEB)(OTCQB: MDBIF), a mental health technology company, is pleased to release an updated company presentation, which is attached to this announcement. The presentation will be used for a series of meetings in the coming weeks.]]>https://www.globenewswire.com/news-release/2018/10/03/1600772/0/en/Medibio-Releases-Corporate-Health-Product-ilumen.html?f=22&fvtc=4&fvtv=34599Medibio Releases Corporate Health Product, ilumen™2018-10-03T13:00:00Z<![CDATA[SYDNEY, Australia and MINNEAPOLIS, Oct. 03, 2018 (GLOBE NEWSWIRE) -- Medibio Limited (MEB or the Company)(ASX: MEB)(OTCQB: MDBIF), a mental health technology company, today announced the release of ilumen™, its product and platform for corporate customers.]]>https://www.globenewswire.com/news-release/2018/10/01/1587827/0/en/Medibio-Named-Finalist-for-Prestigious-Optus-My-Business-Award.html?f=22&fvtc=4&fvtv=34599Medibio Named Finalist for Prestigious Optus My Business Award2018-10-01T13:00:00Z<![CDATA[The awards are the longest-standing business awards program in Australia, identifying and acknowledging the achievements of Australia’s best business operators The awards are the longest-standing business awards program in Australia, identifying and acknowledging the achievements of Australia’s best business operators]]>